Similarly, an increase in the TNF-α and IL-12 cytokine levels and a decrease in TGF-β cytokine level were observed in the TME of TC-1 tumor-bearing mice treated with cisplatin and AnxA5 as compared to those treated with cisplatin only (Fig. 2e). This evidence concerns the gene TGFB1 and neoplasm.